logo
Select company
Select metric
$ -38.52MConsolidated Income
VS
Market
22
Sector
44
Industry
56
History
-
$ 0.62Close
$ 0.36 - $ 4.96 52-Week Range
Ticker Information

Ticker

IBO

Company Name

IMPACT BIOMEDICAL INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

IMPACT BIOMEDICAL INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IBO - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -38.52M
3/31/2025$ -25.05M
12/31/2024$ -24.77M
9/30/2024$ 1.1M
6/30/2024$ -4.32M
3/31/2024$ -4.56M
12/31/2023$ -4.41M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • IMPACT BIOMEDICAL INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -4.41M.
  • Over the past 5 years, IMPACT BIOMEDICAL INC's average Cons. Inc. has been $ -14.36M.
  • The median Cons. Inc. for IMPACT BIOMEDICAL INC during this period was $ -4.56M
  • IMPACT BIOMEDICAL INC reached its highest Cons. Inc. over the past 5 years at $ 1.1M.
  • The lowest Cons. Inc. recorded by IMPACT BIOMEDICAL INC in the same timeframe $ -38.52M

IMPACT BIOMEDICAL INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
CELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC $ -5.77MTCRT : ALAUNOS THERAPEUTICS INC $ -3.99MADTX : ADITXT INC $ -25.88MHSCS : HEARTSCIENCES INC $ -8.77MPMCB : PHARMACYTE BIOTECH INC $ -1.13MAPVO : APTEVO THERAPEUTICS INC $ -24.02MPALI : PALISADE BIO INC $ -11.85MACXP : ACURX PHARMACEUTICALS INC $ -10MGNPX : GENPREX INC $ -17.29MTTNP : TITAN PHARMACEUTICALS INC $ -2.81M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

IBO - Consolidated Income, Last 5 years

$ -38.52M

Minimum

Jun 30, 2025

$ 1.1M

Maximum

Sep 30, 2024

$ -14.36M

Average

$ -4.56M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.09M with a standard deviation of $ 116.52M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.09M
median$ -2.07M
std$ 116.52M